- Previous Close
0.0000 - Open
0.0009 - Bid 0.0009 x --
- Ask 0.0038 x --
- Day's Range
0.0009 - 0.0009 - 52 Week Range
0.0009 - 8.5600 - Volume
58,691 - Avg. Volume
2,406 - Market Cap (intraday)
33,261 - Beta (5Y Monthly) -0.16
- PE Ratio (TTM)
-- - EPS (TTM)
-1.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Holdco Nuvo Group D.G Ltd engages in the research, development, and marketing of medical devices for pregnancy monitoring in Israel, the United States, and internationally. It provides INVU platform, a remote pregnancy monitoring platform that provides expectant mothers with a self -administered wireless sensory band, which enables them and their obstetricians to monitor maternal and fetal heart rate, and maternal uterine activity at home and in the clinic from the 32nd week of pregnancy until the beginning of labor. The company's INVU platform includes a wireless sensory band with multi-modality technology to capture signals to enable the INVU platform; and a cloud computing environment that processes and analyzes data and transmits personalized reports on maternal and fetal health metrics to the expectant mother and her obstetrician through digital visualization tools. It has a collaboration with Royal Philips and Charité Universitätsmedizin Berlin. The company was formerly known as Nuvo Group Ltd. and changed its name to Holdco Nuvo Group D.G Ltd in May 2024. Holdco Nuvo Group D.G Ltd incorporated in 2006 and is headquartered in Tel Aviv, Israel. On August 22, 2024, Holdco Nuvo Group D.G Ltd filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
www.nuvocares.comRecent News: NUVOQ
View MorePerformance Overview: NUVOQ
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NUVOQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NUVOQ
View MoreValuation Measures
Market Cap
29.93k
Enterprise Value
11.05M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.17
Price/Book (mrq)
--
Enterprise Value/Revenue
62.80
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-37.76M
Diluted EPS (ttm)
-1.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
407k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--